<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03350425</url>
  </required_header>
  <id_info>
    <org_study_id>DOPPIO</org_study_id>
    <nct_id>NCT03350425</nct_id>
  </id_info>
  <brief_title>Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients</brief_title>
  <acronym>DOPPIO</acronym>
  <official_title>Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Center for Infection Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators compare two strata of vaccinated patients: those recently vaccinated and
      those vaccinated more than two years ago. The primary objective is to compare pneumonia rates
      between the groups. As exploratory objectives, the investigators will describe the
      anti-pneumococcal antibody titers in hemodialysis patients as a function of time since
      vaccination, and determine factors influencing antibody kinetics. Further exploratory
      objectives investigate the relationship between antibody titers and the incidence of
      pneumonia in hemodialysis patients and extrapolate a possible cut-off for protection from
      pneumonia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participating sites will screen all hemodialysis patients at their outpatient dialysis clinic
      for eligibility. Eligible patients will be approached and informed by their treating
      physician. If a patient agrees to participate in the study and to sign an informed consent
      form, basic data regarding vaccination history, underlying disease, etc. will be entered or
      electronically imported into the study eCRF. Pneumococcal antibody titers will be drawn at
      baseline and every 3 months. For newly vaccinated patients baseline titers will be drawn 4
      weeks after the vaccination. DZIF CTUs will coordinate titer assessment schedules and inform
      the participating physicians of upcoming blood samplings. The samples will be taken on
      dialysis days and thus constitute only a minimal additional burden for both patients and
      physicians. DZIF CTUs will actively follow up on study patients for 2 years after enrolment.
      This follow-up will include validation of all hospitalizations and deaths documented in an
      electronic registry database to assess whether the primary endpoint (pneumonia) occurred.
      Additionally, dialysis units will be contacted every 6 months to assess if pneumonia
      occurred, which did not require hospitalization. DZIF CTUs will document titer assessment
      results in the eCRF. Titers will not be disclosed to the attending physicians because
      revaccination due to knowledge of titers would produce bias. All therapies and diagnostics
      including vaccinations will be administered solely as part of clinical routine and as
      recommended by appropriate guidelines (e.g. RKI STIKO recommendations).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2017</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of pneumonia rates between newly vaccinated hemodialysis patients and those vaccinated against pneumococcal infection more than 2 years ago</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pneumococcal antibody kinetics as a function of time since vaccination.</measure>
    <time_frame>2 years</time_frame>
    <description>Description of antibody titers in hemodialysis patients as a function of time since vaccination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Factors influencing antibody kinetics</measure>
    <time_frame>2 years</time_frame>
    <description>Determination of factors influencing antibody kinetics (e.g. age, prior or ongoing immunosuppression, medication, prior vaccination history) by multiple multivariate models</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Exploration of the relationship between anti-pneumococcal antibody titers and a possible cut-off for protection from pneumonia</measure>
    <time_frame>2 years</time_frame>
    <description>Exploration of the relationship between anti-pneumococcal antibody titers and the incidence of pneumonia in hemodialysis patients and extrapolation of a possible cut-off for protection from pneumonia.</description>
  </other_outcome>
  <other_outcome>
    <measure>Factors influencing pneumonia and vaccine response</measure>
    <time_frame>2 years</time_frame>
    <description>Evaluation of role of patient history (e.g. underlying kidney disease) and clinical course (e.g. prior hospitalizations) on pneumonia and vaccine response.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">884</enrollment>
  <condition>CKD (Chronic Kidney Disease) Stage 5D</condition>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>Recently vaccinated patients</arm_group_label>
    <description>Patients who recently received pneumococcal vaccination.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients vaccinated &gt;2 years ago</arm_group_label>
    <description>Patients who received pneumococcal vaccination more than two years ago.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be obtained for determination of pneumococcal antibody-titers every three
      months for two years. The samples will be taken on dialysis days and thus constitute only a
      minimal additional burden for both patients and physicians
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult hemodialysis patients vaccinated against pneumococcal infection or eligible and
        willing to be vaccinated
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent form including enrolment in registry database (QiN-registry)

          -  Patients with stage 5 chronic kidney disease treated with chronic hemodialysis

          -  Patients who are either already vaccinated or eligible and willing to be vaccinated
             against pneumococcal infection in accordance with current STIKO recommendations

          -  Age of 18 years or older

        Exclusion Criteria:

          -  Patients unwilling/ineligible for vaccination under current STIKO recommendations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Oliver A Cornely, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliver A Cornely, MD</last_name>
    <phone>0049 221 478 85523</phone>
    <email>oliver.cornely@uk-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sibylle C Mellinghoff, MD</last_name>
    <phone>0049 221 478 32884</phone>
    <email>sibylle.mellinghoff@uk-koeln.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital of the Ludwig-Maximilians-University (LMU)</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Bogner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University Hospital Klinikum rechts der Isar - MRI TUM</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Spinner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eberhard Karls University Tübingen</name>
      <address>
        <city>Tübingen</city>
        <state>BW</state>
        <zip>72074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter G. Kremsner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Giessen und Marburg, Giessen site</name>
      <address>
        <city>Gießen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jürgen Lohmeyer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Hessen</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Walter E. Haefeli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Giessen und Marburg, Marburg site</name>
      <address>
        <city>Marburg</city>
        <state>Hessen</state>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Gress, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hannover Medical School</name>
      <address>
        <city>Hannover</city>
        <state>NI</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Welte, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Bonn</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Coch, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver A. Cornely, MD</last_name>
      <email>oliver.cornely@uk-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Sibylle C. Mellinghoff, MD</last_name>
      <email>sibylle.mellinghoff@uk-koeln.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical Clinic, Research Center Borstel</name>
      <address>
        <city>Borstel</city>
        <state>SH</state>
        <zip>23845</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Herzmann, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein, Campus Lübeck</name>
      <address>
        <city>Lübeck</city>
        <state>SH</state>
        <zip>23562</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Rupp, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julian Schulze zur Wiesch, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2017</study_first_posted>
  <last_update_submitted>February 2, 2018</last_update_submitted>
  <last_update_submitted_qc>February 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Oliver Cornely, MD</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>hemodialysis</keyword>
  <keyword>pneumococcal vaccination</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

